news

Barron Venture Partners Launches Fund to Back Transformative Technologies

NORWALK, Conn., Oct. 13, 2025 /PRNewswire/ -- Barron Venture Partners, a new venture capital firm led by Andrew Worden, has…

6 months ago

Plume Joins prpl Foundation to Drive Ecosystem Collaboration and Openness

Committed to providing solutions based on open standards that create business value through consumer experience innovation PALO ALTO, Calif., Oct.…

6 months ago

MiTAC Computing Showcases Future-Ready AI Cluster Solutions at the 2025 OCP Global Summit to Empower Open and Energy-Efficient Data Centers

SAN JOSE, Calif., Oct. 13, 2025 /PRNewswire/ -- MiTAC Computing Technology, a global leader in high-performance and energy-efficient server solutions,…

6 months ago

DZYNE Expands Dronebuster Line with New Vehicle Kits at AUSA 2025

Autonomous and Manual Kits deliver mobile, layered counter-drone defense, building on 2,500+ systems fielded in over 50 countries WASHINGTON, Oct.…

6 months ago

Paris 2024 Fair Play Awards presented at Olympic Museum

13 October 2025 - Decathlete Sander Skotheim, the German Olympic Sports Confederation (DOSB) and its national rowing federation, and DJ Antonio…

6 months ago

High Commissioner Grandi: We have really unveiled, fully, the incredible power of sport

13 October 2025 - Speaking at the 76th Session of the UNHCR Executive Committee, UN High Commissioner for Refugees Filippo Grandi highlighted the…

6 months ago

Lamborghini returns to FIA Macau GT World Cup with twocar factory entry

Mortara and Engstler head up Absolute Corse entry on final full season outing for Huracán GT3Sant’Agata Bolognese, 13 October 2025…

6 months ago

Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

-   Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET -   Poster presentation on preclinical evaluation of petosemtamab…

6 months ago

Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company…

6 months ago

Press release: Transparency Notification from Shareholder

Transparency Notification from Shareholder Ghent, Belgium – 13 October 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or…

6 months ago